Prognostic impact of epithelial cell adhesion molecule in ovarian cancer patients.

about

NDRG2 Expression Decreases Tumor-Induced Osteoclast Differentiation by Down-regulating ICAM1 in Breast Cancer Cells.Surface Profiling of Extracellular Vesicles from Plasma or Ascites Fluid Using DotScan Antibody Microarrays.

P2860

Q36436508-E632D334-1386-4D17-B050-37B60F0C68F2 Q50908901-0EF96876-FA77-4B19-9EE4-E05ABC47AE39

P2860

Prognostic impact of epithelial cell adhesion molecule in ovarian cancer patients.

Item

http://www.wikidata.org/entity/Q42942406

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Prognostic impact of epithelial cell adhesion molecule in ovarian cancer patients.

@en

Prognostic impact of epithelial cell adhesion molecule in ovarian cancer patients.

@nl

type

Item

label

Prognostic impact of epithelial cell adhesion molecule in ovarian cancer patients.

@en

Prognostic impact of epithelial cell adhesion molecule in ovarian cancer patients.

@nl

prefLabel

Prognostic impact of epithelial cell adhesion molecule in ovarian cancer patients.

@en

Prognostic impact of epithelial cell adhesion molecule in ovarian cancer patients.

@nl

P1476

Prognostic impact of epithelial cell adhesion molecule in ovarian cancer patients

@en

P2093

Maria Lee

http://www.w3.org/2001/XMLSchema#string

P2860

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

EpCAM (CD326) finding its role in cancer

Epithelial cell adhesion molecule expression (CD326) in cancer: a short review

EpCAM in carcinogenesis: the good, the bad or the ugly

Overexpression of the epithelial cell adhesion molecule is associated with a more favorable prognosis and response to platinum-based chemotherapy in ovarian cancer

Humoral response to catumaxomab correlates with clinical outcome: results of the pivotal phase II/III study in patients with malignant ascites

Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.

A tumor-associated glycoprotein that blocks MHC class II-dependent antigen presentation by dendritic cells.

Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival.

Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer.

P304

352-354

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3802/JGO.2014.25.4.352

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maria Lee

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266951500

http://www.w3.org/2001/XMLSchema#string

P698

25310035

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

P932

4195308

http://www.w3.org/2001/XMLSchema#string

Prognostic impact of epithelial cell adhesion molecule in ovarian cancer patients.

about

P2860

P2860

Prognostic impact of epithelial cell adhesion molecule in ovarian cancer patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932